ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Impel Pharmaceuticals Inc

Impel Pharmaceuticals Inc (IMPL)

0.2411
0.00
(0.00%)
Closed April 27 4:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.2411
Bid
0.19
Ask
0.1901
Volume
-
0.00 Day's Range 0.00
0.19 52 Week Range 2.87
Market Cap
Previous Close
0.2411
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
23,739,000
Dividend Yield
-
PE Ratio
-0.05
Earnings Per Share (EPS)
-4.48
Revenue
12.65M
Net Profit
-106.31M

About Impel Pharmaceuticals Inc

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous sy... Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Impel Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMPL. The last closing price for Impel Pharmaceuticals was $0.24. Over the last year, Impel Pharmaceuticals shares have traded in a share price range of $ 0.19 to $ 2.87.

Impel Pharmaceuticals currently has 23,739,000 shares outstanding. The market capitalization of Impel Pharmaceuticals is $5.70 million. Impel Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.05.

IMPL Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
26-0.0489-16.86206896550.291.060.1916071630.6319163CS
52-1.4089-85.38787878791.652.870.199826330.93705879CS
156-14.0589-98.31398601414.334.750.193628154.77129132CS
260-15.0689-98.425212279615.3134.750.193658614.87158781CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
bigstocksnbonds bigstocksnbonds 5 minutes ago
Hope they call you soon or you can call them Monday!!
louieforpar louieforpar 6 minutes ago
“In total, the president’s father and mother transferred over $1 billion to their children, according to the Times tally.”





https://www.google.com/url?q=https://apnews.com/article/0452d29cd2564eaf97605ab90acc3a67&sa=U&ved=2ahUKEwjXwZGkkOKFAxVw5MkDHbmjAck
DJT
TRAPPER JIM TRAPPER JIM 8 minutes ago
I hope so. They still haven’t called me back yet. I checked back at the end of the day with the lady I had spoke to. She said that if I hadn’t heard anything over the weekend to call her on Monday
weedtrader420 weedtrader420 10 minutes ago
BITCOIN LITECOIN Year Of The Cat $75,000 TARGET
BTCUSD
valleybenedetto valleybenedetto 11 minutes ago
My pleasure and we appreciate you
CLNV
Mr Michael Mr Michael 12 minutes ago
Hi Mellon,

Great insights and advice!
I certainly appreciate what you have said:
“You should know being humble is lucrative”

Thank you for sharing and being such a positive and inspiring voice of this community.

Michael
FNMA
weedtrader420 weedtrader420 14 minutes ago
BITCOIN LITECOIN Cat Stevens MORNING HAS BROKEN ☀️ 🐋 $75,000 TARGET
BTCUSD
ddls ddls 14 minutes ago
BioElectronics is a loser company and thus stock.

You also need to STOP PRETENDING.
BIEL
Vettelover98 Vettelover98 15 minutes ago
No one asked you for your opinion. Have a good day 🖕
APRU
Beano1969 Beano1969 18 minutes ago
🤣🤣🤣❣️ that's some funny 💩❣️
VGLS
pacman181 pacman181 22 minutes ago
He screwed a lot of people but that was his aim so he could benefit off....the trials and susidiary in India, even the hospitals that were fighting for it, all a big fake lie...
GSTC
CaptainObvious CaptainObvious 23 minutes ago
04/27/24 - 1,205,420,320
04/26/24 - 1,205,197,045
04/23/24 - 1,204,236,917
04/20/24 - 1,204,039,742
04/17/24 - 1,203,973,067
04/12/24 - 1,203,199,607
04/11/24 - 1,201,099,732
04/10/24 - 1,200,500,107
04/06/24 - 1,199,672,730
04/05/24 - 1
NWBO
The Danish Dude The Danish Dude 24 minutes ago
Three Revimmune entities.

SAS - France
Inc - US
Ltd - UK

Linda Powers director in US and UK and in full control. Revimmune trials with Interleukin-7 back more than a decade gets PR'ed as Revimmune Inc. Revimmune.com say Maryland Bethesda is head office. He
NWBO
Spuds McKenz66 Spuds McKenz66 24 minutes ago
fed will probably hold the rate , so I'll close out on SQQQ
SQQQ
jerrybrockman jerrybrockman 27 minutes ago
You always need to be vigilant, especially these days.
EMKR
eagle8 eagle8 29 minutes ago
Thanks to d_stock:

https://www.biospace.com/article/fda-requires-boxed-warning-for-secondary-cancers-on-car-t-therapies/?keywords=CAR+T
NWBO
jimr1717 jimr1717 31 minutes ago
🏆️ The long list of Hedge Funds Holding this





























IFUS
frrol frrol 32 minutes ago
Yes. It's a decent response, just gets stumped because the 7 month clock starts with our Rapporteur Appointment request, which we have not announced. Though no idea how it came up with April (and May).

Keep in mind that these AIs often give flawed responses. (Gemini warns you of that
AVXL
SeekTruthAlways SeekTruthAlways 36 minutes ago
Lighter than Air due to having no brain cells and being brainwashed the Old Man Holcomb and Crooked Wife who will have to answer soon to investors, media, and others, unless they abscond to Ireland, or another country like they did to New Zealand and Australia previously, where legal matters are afo
ASRE
flptrnkng flptrnkng 38 minutes ago
Half a billion here, half a billion there, pretty soon you're talking a maxxed OS
IGPK

Your Recent History

Delayed Upgrade Clock